Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

The presented protocol uses flow cytometry to quantify the number of proliferating and dead cells in cultured mouse enteroids. This method is helpful to evaluate the effects of drug treatment on organoid proliferation and survival.

Abstract

The intestinal epithelium acts as a barrier that prevents luminal contents, such as pathogenic microbiota and toxins, from entering the rest of the body. Epithelial barrier function requires the integrity of intestinal epithelial cells. While epithelial cell proliferation maintains a continuous layer of cells that forms a barrier, epithelial damage leads to barrier dysfunction. As a result, luminal contents can across the intestinal barrier via an unrestricted pathway. Dysfunction of intestinal barrier has been associated with many intestinal diseases, such as inflammatory bowel disease. Isolated mouse intestinal crypts can be cultured and maintained as crypt-villus-like structures, which are termed intestinal organoids or “enteroids”. Enteroids are ideal to study the proliferation and cell death of intestinal epithelial cells in vitro. In this protocol, we describe a simple method to quantify the number of proliferative and dead cells in cultured enteroids. 5-ethynyl-2’-deoxyuridine (EdU) and propidium iodide are used to label proliferating and dead cells in enteroids, and the proportion of proliferating and dead cells are then analyzed by flow cytometry. This is a useful tool to test the effects of drug treatment on intestinal epithelial cell proliferation and cell survival.

Introduction

A fundamental function of intestinal epithelial cells is to protect the entry of luminal contents such as pathogenic bacteria and toxins1,2. To perform such a function, intestinal stem cells continuously proliferate and differentiate into a variety of epithelial cells, including enterocytes and secretory cells, which form a barrier by forming tight connections3. The rapid renewal of intestinal epithelial cells requires strict coordination of cell proliferation, cell differentiation, and cell death4,5. Reduced cell proliferation ....

Protocol

This protocol was approved by the Animal Care and Use Committee of Cambridge-Suda Genomic Resource Center (CAM-SU) at Soochow University.

1. Intestinal Organoid Isolation and Culture

  1. Isolation of intestinal crypts and enteroid culture
    1. Euthanize an 8-week-old wild-type mouse with CO2 inhalation. Use tissue forceps and fine iris scissors to dissect out approximately 8 cm of ileum.
    2. Flush out using a syringe with gavage feeding needle with about 40 mL .......

Representative Results

Small intestinal crypts were isolated and cultured as enteroids in basement membrane matrix. Enteroids started to form buds 2 days after isolation. On day 6, enteroids had many buds with lots of debris (dead cells) in the lumen. Enteroids were ready to be passaged at this stage (Figure 3).

Numerous studies have shown that inflammatory cytokines are essential for the maintenance of intestinal epithelial homeostasis. Abnormal expression of inflammatory cytokines is .......

Discussion

This protocol details the steps necessary for the culture of enteroids in vitro and quantification of EdU- and PI-positive cells in the enteroids by flow cytometry. There are several advantages of this strategy. First, EdU labelling is used to detect proliferating cells in enteroids. Compared with traditional BrdU assay, EdU labelling method is faster, more sensitive, and more accurate. EdU is very similar to thymine (T), which replaces thymine in DNA synthesis during cell division. Compared to the BrdU antibody, EdU is .......

Acknowledgements

This work is supported by The National Natural Science Foundation of China (31971062, 31900326, and 31601022), The Natural Science Foundation of Jiangsu Province (BK20190043, BK20180838), Research Fund of State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University (KF-GN-202004). The Natural Science Foundation of the Jiangsu Higher Education Institutions of China (19KJB320003), The Livelihood and Technology Program of Suzhou City (SYS2019030), and The Research Innovation Program for College Graduates of Jiangsu Province (KYCX19-1981). This work is also supported by Tang Scholar of Soochow University.

....

Materials

NameCompanyCatalog NumberComments
15 ml centrifuge tubeCorning430791
22 G gavage needleVWR20068-608
24-well plateNunc142475
40 mm sterile cell strainerBD352340
50 ml centrifuge tubeCorning430829
70 mm sterile cell strainerBD352350
Advanced DMEM/F-12GIBCO12634010
Attune NxT Acoustic Focusing CytometerInvitrogenA24863
B-27 SupplementGIBCO17504044
Buffer 12 mM EDTA in DPBS
Buffer 254.9 mM D-sorbitol, 43.4 mM sucrose in DPBS
C57/B6 miceNanjing Biomedical Research Institute of Nanjing University
Cell-dissociation enzymes (TrypLE)Life technologies12605-010
CentrifugeEppendorf5424
CentrifugeEppendorf5424R
CentrifugeEppendorf5810R
Click-iT Plus EdU Alexa Fluor 594 Imaging KitLife technologiesC10639
CO2 incubatorPanasonicMCO-18AC
DPBSGIBCO14190144
D-sorbitolBBISB0491
EDTABBIEB0185
ENR mediaMinigut media, 50 ng/ml EGF, 100 ng/ml Noggin, 500 ng/ml R-spondin
Fetal Bovine Serum (FBS)Gibco10270-106
Fine Iris ScissorsTansoole2037454
Fluorescence microscopeOlympusFV1000
GlutaMAX SupplementGIBCO35050-061
Goat SerumLife technologies16210-064
HDMEMHycloneSH30243.01B
HEPESSigmaH4034
MatrigelCorning356231
Minigut mediaAdvanced DMEM/F12, 2 mM Glutamax, Penn/Strep (100 units/ml), 10 mM Hepes, N2 supplement (1:100), B27 supplement (1:50)
N2 supplementR&DAR009
Nonionic surfactant (Triton X)BBITB0198-500ML
Operating Scissor (12.5 cm)Tansoole2025785
Paraformaldehyde (PFA)sigma158127-500g
Penn/StrepInvitrogen15140-148
Phase contrast microscopeNikonTS1000
Propidium iodideSigmaP4170-25MG
Recombinant EGFPeproTech315-09
Recombinant Mouse NogginPeproTech250-38
Recombinant Mouse R-Spondin 1R&D3474-RS-050
Recombinant Murine IL-22PeproTech210-22-10
SucroseBBISB0498
Tissue ForcepsTansoole2026704
Y-27632 2HC1SelleckS1049

References

  1. Odenwald, M. A., Turner, J. R. The intestinal epithelial barrier: a therapeutic target. Nature reviews. Gastroenterology & Hepatology. 14 (1), 9-21 (2017).
  2. Buckley, A., Turner, J. R. Cell Biology of Tight Junction Barrier Regul....

Explore More Articles

EnteroidProliferationCell DeathIntestinal Epithelial CellsInflammatory Bowel DiseaseOrganoidIntestinal CryptBasement Membrane Matrix

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved